RMB. are you in AMLX ...chk Ernie's recent post
Kiwi
Kiwi
Recent AMLX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:00:07 PM
- Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation • Business Wire • 05/15/2026 04:11:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 11:04:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:02:56 AM
- Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results • Business Wire • 05/07/2026 11:00:00 AM
- Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 05/06/2026 01:00:00 PM
- Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia • Business Wire • 05/05/2026 11:00:00 AM
- Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 • Business Wire • 04/30/2026 01:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2026 11:03:13 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 11:02:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 11:01:02 AM
- Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference • Business Wire • 04/08/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 11:11:11 AM
- Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia • Business Wire • 03/24/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:00:02 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/03/2026 09:03:34 PM
- Amylyx Shares Slip Despite Q4 Beat as Investors Focus on Trial Timeline • IH Market News • 03/03/2026 03:54:22 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/03/2026 01:01:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2026 12:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:02:50 PM
- Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 03/03/2026 12:00:00 PM
